Genetic Variant Associated With Resistance To Chemotherapy Drug In Women With Breast

[News]

Researchers have found links between an individual's genetics and their response to treatment with chemotherapy. The findings, by researchers at the National Cancer Institute (NCI), part of the National Institutes of Health, and colleagues, show how a genetic variation, located in the SOD2 gene, may affect how a person responds to the chemotherapy drug cyclophosphamide. Cyclophosphamide is used in the treatment of breast and other cancers.

More... (http://www.medicalnewstoday.com/articles/153316.php)